Baxter Revenue 2024. Bax) just reported results for the first quarter of 2024. For fiscal 2024, baxter now expects adjusted earnings, before special items, of $2.88 to $2.98 per share and sales growth of around 2 percent on a reported basis and.
Baxter annual revenue for 2023 was $14.813b, a 2.12%. This is 5.39 percentage points lower than the us medical instruments & supplies industry revenue.
The new company’s operating model is close to being finalized, and the spinoff is expected to occur by july 2024.
Revenue In The Quarter Ending March 31, 2024 Was.
Images References :
Baxter Annual Revenue For 2023 Was $14.813B, A 2.12%.
This is 5.39 percentage points lower than the us medical instruments & supplies industry revenue.
Baxter Expects Sales Growth Of Approximately 2% On Both A Reported And Constant Currency Basis.
For fiscal 2024, baxter now expects adjusted earnings, before special items, of $2.88 to $2.98 per share and sales growth of around 2 percent on a reported basis and.
Baxter Expects Sales Growth Of Approximately 2% On Both A Reported And Constant Currency Basis.